Literature summary for 3.2.1.76 extracted from

Tylki-Szymanska, A.; Rozdzynska, A.; Jurecka, A.; Marucha, J.; Czartoryska, B.
Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase) (2010), Mol. Genet. Metab., 99, 10-17.

Search for more literature for 3.2.1.76

Application

Application	Comment	Organism
medicine	the enzyme is useful in treatment of mucopolysaccharidosis type I, MPS I, by enzyme replacement therapy	Homo sapiens

Protein Variants

Protein Variants	Comment	Organism
additional information	mutations in the IDUA gene cause mucopolysaccharidosis type I, MPS I, a progressive multisystem disorder, phenotypes, overview. Growth patterns in terms of body height, weight, head and chest circumference in patients with MPS I without treatment and after enzyme replacement therapy with alpha-L-iduronidase, overview	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining

Synonyms

Synonyms	Comment	Organism
alpha-L-iduronidase	-	Homo sapiens
laronidase	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)